Mereo BioPharma Group PLC | Key People and Executives
Peter John Fellner
Chairman
Denise Vera Pollard-Knight
Chief Executive Officer & Executive Director
Richard C. M. Jones
Chief Financial Officer & Executive Director
Frank Murdoch Armstrong
Senior Independent Non-Executive Director
Peter John Fellner
Chairman
Denise Vera Pollard-Knight
Chief Executive Officer & Executive Director
Richard C. M. Jones
Chief Financial Officer & Executive Director
Alastair G. MacKinnon
Chief Medical Officer
Jerome Dauvergne
Head-Pharmaceutical Development
Wills Hughes-Wilson
Head-Patient Access & Commercial
John P. Richard
Head-Corporate Development
Charles E. Sermon
Secretary & General Counsel
Paul Frederick Blackburn
Non-Executive Director
Kunal Ashok Kashyap
Non-Executive Director
Peter James Jonathan Bains
Non-Executive Director
Anders Olof Adolf Ekblom
Non-Executive Director
Julian Lord
Financial Controller
Frank Murdoch Armstrong
Senior Independent Non-Executive Director
| Address |
1 Cavendish Place
London Greater London W1G 0QF
United Kingdom
|
|
Employees
|
- |
| Website |
http://mereobiopharma.com/ |
| Updated |
07/08/2019 |
| Mereo BioPharma Group Plc engages in the acquisition, development, and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare and specialty diseases. It focuses on the treatment of patients with Osteogenesis Imperfecta, Alpha-1 Antitrypsin Deficiency, Hypogonadotropic Hypogonadism in obese men, and Acute Exacerbations of Chronic Obstructive Pulmonary Disease. The company was founded by Denise Vera Pollard-Knight, Charles Sermon, Alastair MacKinnon, and John Richard in March 2015 and is headquartered in London, the United Kingdom. |
